Juvenal Tobin W's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Sep 16, 2026
- Accession no.
- 0001628280-26-062255
- Filed
- Sep 16, 2026, 4:20 PM ET
- Trade date
- Sep 14-15, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $222.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Juvenal Tobin WCIK 0001856542 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Common Stock | SSaleDisposed | −3,306 | $32.32 | −$106,863.14 | 61,878 | Direct | |
| Sep 15, 2026 | Common Stock | SSaleDisposed | −3,294 | $35.14 | −$115,757.75 | 58,584 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.